drugset / Trial / NCT00119652
Seroquel in Bipolar Depression Versus SSRI
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paroxetine | Small molecule | 20 mg | — |
| Subject | Quetiapine | Small molecule | 300 mg | — |
| Subject | Quetiapine | Small molecule | 600 mg | — |